The German Statutory Health Insurance Association (GKV-Spitzenverband) has expressed its support for the Bundestag’s decision to investigate the issue of pre-natal tests. A spokesperson for the GKV told the “Rheinische Post” that molecular genetic testing in pregnancy raises critically important questions that extend beyond the purely medical realm, touching upon ethical and broader societal concerns.
The GKV spokesperson added that the Joint Federal Committee (Gemeinsamer Bundesausschuss), even before the new NIPT testing method was introduced, had already signaled these concerns in several letters addressed to the Federal Ministry of Health and members of the German Bundestag, urging for a comprehensive societal debate within the Bundestag itself.
The GKV-Spitzenverband stressed that the Joint Federal Committee could only support its prior decisions regarding the new testing methods by relying on the prevailing body of law and available medical-scientific data, as it did not possess a political mandate. Given this context, the Association welcomed the move to initiate an overarching debate on this significant topic within the German Bundestag.
